# Decoded Longevity

> Longevity infrastructure for clinicians and patients across Africa, Southeast Asia, and beyond. Machine-readable firm overview, regulatory snapshots, journal rests-on, the practitioner toolkit registry, and the Practice AI tier scaffolds live at canonical URLs below.

## Site
- [Home](https://decodedlongevity.com/)
- [About](https://decodedlongevity.com/about)
- [Partner](https://decodedlongevity.com/partner)
- [Portfolio](https://decodedlongevity.com/portfolio)
- [Practice AI — service line](https://decodedlongevity.com/practice-ai)
- [Practitioners — landing](https://decodedlongevity.com/practitioners)
- [Practitioners — portal (gated)](https://decodedlongevity.com/practitioners/portal)
- [Press](https://decodedlongevity.com/press)
- [Contact](https://decodedlongevity.com/contact)
- [Journal index](https://decodedlongevity.com/journal)

## Agent surfaces
- [/.well-known/mcp.json](https://decodedlongevity.com/.well-known/mcp.json) — MCP discovery
- [/agents.json](https://decodedlongevity.com/agents.json) — Wildcard agent manifest
- [/api/manifest](https://decodedlongevity.com/api/manifest) — OpenAPI for REST tool mirror
- [/llms-full.txt](https://decodedlongevity.com/llms-full.txt) — expanded machine-readable map
- [/sitemap.xml](https://decodedlongevity.com/sitemap.xml) — sitemap index (per-URL lastmod)

## Interactive endpoints (STEP 6 — public, JSON-in JSON-out)
- POST [/api/agent/chat](https://decodedlongevity.com/api/agent/chat) — SSE streaming Q&A backed by search_content
- POST [/api/agent/simulate_regulatory_pathway](https://decodedlongevity.com/api/agent/simulate_regulatory_pathway) — deterministic per-market regulatory scaffold
- POST [/api/agent/assess_brand_fit](https://decodedlongevity.com/api/agent/assess_brand_fit) — five-question heuristic brand-fit screen
- POST [/api/agent/search_content](https://decodedlongevity.com/api/agent/search_content) — keyword search across firm copy + journal

## Practice areas
- [Premium supplements](https://decodedlongevity.com/categories/supplements)
- [Functional food and beverage](https://decodedlongevity.com/categories/functional-food-and-beverage)
- [Cosmeceuticals](https://decodedlongevity.com/categories/cosmeceuticals)
- [Aesthetic and wellness devices](https://decodedlongevity.com/categories/medical-devices)
- [Longevity protocols](https://decodedlongevity.com/categories/longevity)
- [Wellness and recovery](https://decodedlongevity.com/categories/vein-and-veldt)
- [Clinical equipment](https://decodedlongevity.com/categories/clinical-equipment)

## MCP tools
- get_firm_overview
- get_regulatory_status
- get_category_capability — six practice-area thesis records, including clinical-equipment
- get_journal_posts — surfaces rests_on key data points
- search_content
- simulate_regulatory_pathway
- assess_brand_fit
- submit_partner_inquiry — bearer-gated
- get_practitioner_toolkit_item — curated AI/clinical-software directory
- get_practice_ai_tier — Foundation / Growth / Transformation tier scaffolds (pricing inquiry-gated)

## Navigation
- [Practice](https://decodedlongevity.com/portfolio)
- [Practice AI](https://decodedlongevity.com/practice-ai)
- [Partner](https://decodedlongevity.com/partner)
- [Journal](https://decodedlongevity.com/journal)
- [Press](https://decodedlongevity.com/press)
- [Practitioners](https://decodedlongevity.com/practitioners)


## Journal articles (with rests-on)
### The OpenEvidence Alternative Stack for SEA/SA Practitioners

OpenEvidence remains gated behind a US National Provider Identifier check, locking out clinicians in Singapore, Johannesburg and everywhere between. The practical workaround is a three-tool stack — and it costs less than US$30 a month.

- Category: Practitioner Tools
- Published: 2026-05-12
- Last reviewed: 2026-05-12
- Reading time: 6 min

**Rests on:**
- OpenEvidence required NPI verification and reached approximately 20 million monthly consultations in January 2026 (Sacra, 2026).
- Consensus Premium is US$10/month on annual billing, with a permanent free tier including 10 Pro Analyses/month (Consensus pricing page, 2026).
- Elicit Plus is US$10/month annual; Pro is US$42/month for higher report limits (Elicit pricing page, 2026).
- Heidi Evidence, launched 24 February 2026, supports cited answers from BMJ Group, NICE, HealthPathways, EMGuidance, MIMS and Vidal (Heidi Health announcement, 2026).

- [Read article](https://decodedlongevity.com/journal/openevidence-alternative-sea-sa)

### Indonesia's October 2026 Halal Mandate — What Distributors Need to Know

BPJPH's 17 October 2026 deadline for cosmetics, supplements and chemical products is now five months away. Distributors without halal certification or registered SHLN by August 2026 should plan for delisting.

- Category: Regulatory
- Published: 2026-05-08
- Last reviewed: 2026-05-08
- Reading time: 7 min

**Rests on:**
- Government Regulation 42/2024 sets 17 October 2026 as the mandatory halal deadline for cosmetics, pharmaceuticals, chemical products and consumer goods (BPJPH statement, 13 May 2025).
- Statutory new-application fee for foreign or large-enterprise cosmetics is IDR 12,500,000 under Kepala BPJPH Decree 141/2021 (Kompas, 2022).
- LPH inspection ceiling for chemical-category cosmetics, medium/large/foreign, is IDR 6,468,750 (BPJPH unit cost schedule).
- Halal certificates issued under PP 42/2024 are valid for 4 years, contingent on no changes to ingredients or processes (Insightof.id, 2025).

- [Read article](https://decodedlongevity.com/journal/indonesia-halal-october-2026)

### ACD Singapore — The 39th and 40th Substance Class Changes

The ASEAN Cosmetic Committee's 2024-2025 meetings moved Acid Yellow 3 to Annex III with a 24-month grace ending 14 May 2026, restricted zinc pyrithione, and added phenacetin to the prohibited list. HSA's December 2025 annex update reflects all of it.

- Category: Regulatory
- Published: 2026-05-02
- Last reviewed: 2026-05-02
- Reading time: 6 min

**Rests on:**
- HSA's ACD annex landing page was last updated December 2025 (HSA, 2025).
- Acid Yellow 3 moves from Annex II to Annex III; non-compliant products must be off-shelf by 14 May 2026 (Philippine FDA Circular 2025-002).
- Phenacetin and acrylate monomers were added to Annex II at the July 2025 ACC update version 2025-1 (CIRS / SGS Safeguards, 2025).
- Annex VII UV filter revisions, including combined-use caps and benzophenone trace limits, take effect 15 November 2026 (ChemLinked, 2025).

- [Read article](https://decodedlongevity.com/journal/acd-39th-40th-changes)

### GLP-1 Compounding in Sub-Saharan Africa — Regulatory Reality 2026

SAHPRA's March 2025 intention to declare compounded GLP-1s undesirable has not been finalised, and the trade continues. MCAZ Zimbabwe issued its first public Ozempic warning in June 2025. The compounding window is closing, unevenly.

- Category: Regulatory
- Published: 2026-04-28
- Last reviewed: 2026-04-28
- Reading time: 7 min

**Rests on:**
- SAHPRA's 5 March 2025 Communication to Stakeholders signalled intent to declare compounded GLP-1 products undesirable under section 23 of the Medicines Act (Cliffe Dekker Hofmeyr, 2026).
- SAHPRA employs 12 inspectors to police the compounded GLP-1 trade, per CEO Boitumelo Semete-Makokotlela (Times Live, January 2026).
- MCAZ and HPA Zimbabwe issued a joint public warning on Ozempic dated 6 June 2025 (MCAZ media release).
- Mounjaro (tirzepatide) is not registered in South Africa for weight management; SAHPRA is reviewing an application from Aspen Pharmacare (SANews).

- [Read article](https://decodedlongevity.com/journal/glp1-compounding-ssa-2026)

### The Practitioner Tool Stack — What 500+ SEA Clinics Actually Use

Pabau, Cliniko and Fresha dominate the practice-management layer; Heidi and Glass have become the de facto AI-scribe defaults. The premium versus mass-market split in Orchard Road versus Manila is wider than vendor websites suggest.

- Category: Practitioner Tools
- Published: 2026-04-22
- Last reviewed: 2026-04-22
- Reading time: 7 min

**Rests on:**
- Pabau pricing in Singapore aesthetic clinics runs S$300-750/month for comprehensive deployments (Consentz, 2026).
- Cliniko pricing starts at US$45/month for a single practitioner, scaling to US$395/month for 26-200 practitioners (Pabau pricing comparison, 2026).
- Heidi Health Clinician plan is US$150/month annual in 2026; the platform supports 2M+ consults weekly in 110 languages across 116 countries (Heidi Health Series B announcement, 2025; Vero Scribe, 2026).
- DAX Copilot (Nuance/Microsoft) sits at approximately US$600/month per provider for enterprise health system deployments (Commure, 2026).

- [Read article](https://decodedlongevity.com/journal/practitioner-tool-stack-2026)

### Thailand's FDA on Imported Aesthetic Devices — 2026 Updates

The Thai FDA's January 2026 Manufacturing License Announcement, effective May 2026, restructures how energy-based aesthetic devices are evaluated. HIFU and RF microneedling sit at Class 2-3 and now face activity-based facility scrutiny.

- Category: Regulatory
- Published: 2026-04-15
- Last reviewed: 2026-04-15
- Reading time: 6 min

**Rests on:**
- Thai FDA's facility licensing Announcement was issued 15 January 2026, gazetted 2 March 2026, effective May 2026 (Medical Device Thailand, 2026).
- Class 1 devices on the FDA Positive List have been auto-approved on submission since January 2025 (Thai FDA e-Submission system).
- Thailand's medical device market is approximately US$7 billion with over 80% imported (MedDeviceGuide, 2026).
- Medical device licences in Thailand are valid for 5 years and require renewal (Artixio, 2026).

- [Read article](https://decodedlongevity.com/journal/thailand-fda-aesthetic-devices-2026)

### Malaysia NPRA — Health Supplement vs. Pharmaceutical Classification

NPRA's Food-Drug Interphase framework is where most longevity supplements get caught. NMN, NR and similar bioactives sit closer to the drug boundary in Malaysia than in Singapore or Thailand.

- Category: Regulatory
- Published: 2026-04-08
- Last reviewed: 2026-04-08
- Reading time: 6 min

**Rests on:**
- NPRA's DRGD 3rd Edition 11th Revision was issued January 2026 (NPRA, 2026).
- The Food-Drug Interphase classification framework was established by joint NPRA-FSQD committee in 2000 (NPRA Product Classification Guideline).
- Ingredients triggering automatic drug classification include paracetamol, glucosamine, tranexamic acid, aspirin and Poisons Act 1952 substances (NPRA Reference Circular Pekeliling Kriteria Baru Pengkelasan Produk, 07 August 2014).
- Plant sterols/stanols at ≥3.5 g/day intake automatically classify as drug-regulated (NPRA Product Classification Guideline).

- [Read article](https://decodedlongevity.com/journal/malaysia-npra-supplement-classification)

### Philippines FDA — The CPR Process for Cosmetics & Health Supplements

The Philippine FDA's Certificate of Product Registration process is slower than its ASEAN neighbours but defines access to the BGC and Makati premium clinic concentration. Cosmetics run 15-30 working days under CPN; food supplements via CPR run 20-60.

- Category: Regulatory
- Published: 2026-04-01
- Last reviewed: 2026-04-01
- Reading time: 6 min

**Rests on:**
- PFDA cosmetics processing under CPN typically runs 15-30 working days (TeamBench, 2026).
- Food and food supplement CPRs run 20-60 working days; drugs run 60-120 working days (TeamBench, 2026).
- Penalties for selling unregistered products under RA 9711 range from PHP 50,000 to PHP 5,000,000 plus imprisonment of 1-10 years (FDA Philippines).
- Cosmetics CPN validity is 1 year initial, extending to 3 years on renewal (FilePino, 2026).

- [Read article](https://decodedlongevity.com/journal/philippines-fda-cpr-process)

### South Africa's SAHPRA — Complementary Medicines Reclassification 2026

SAHPRA's Category D complementary medicines framework is operational but unevenly enforced. The recent reclassification of paediatric zinc picolinate and selenium signals tighter scrutiny on what counts as a 'low risk' supplement.

- Category: Regulatory
- Published: 2026-03-25
- Last reviewed: 2026-03-25
- Reading time: 6 min

**Rests on:**
- SAHPRA's Complementary Medicines category was established 15 November 2013 and broadened 25 August 2017 under Government Notice 859 in GG 41064 (SAHPRA).
- SAHPRA reclassified paediatric zinc picolinate and selenium products to Category A with 6-month withdrawal deadline (Devdiscourse, reproducing SAHPRA notice).
- SAHPRA's GMP guidelines were updated in April 2026 (Quicknews, 8 May 2026).
- The eCTD format is mandatory for human medicines applications excluding complementary and veterinary medicines (Freyr Solutions, 2025).

- [Read article](https://decodedlongevity.com/journal/sahpra-complementary-medicines-2026)

### Vein & Veldt — The Vascular Health Category Nobody's Building

Cardiovascular disease drives 31% of global deaths, but the longevity industry over-indexes on metabolic and senolytic plays. Vascular tone, endothelial function and venous insufficiency are an underserved category — particularly in aging SEA and SSA urban professional segments.

- Category: Market Intel
- Published: 2026-03-18
- Last reviewed: 2026-03-18
- Reading time: 7 min

**Rests on:**
- South African national prevalence: coronary heart disease 1.29 per 100, stroke 4.29 per 100 (Keates et al., 2018 systematic review, PMC 8756070).
- Cardiometabolic multi-morbidity affects 10.5% of South African adults; adjusted OR for over-75 cohort is 49.54 versus 15-29 (PMC 9593353).
- Cesarone et al. (Clin Appl Thromb Hemost. 2006;12(2):205-12, PMID 16708123) demonstrated Pycnogenol's superiority to diosmin/hesperidin combination on CVI parameters in an 86-patient controlled trial.
- Cardiovascular disease accounts for 31% of global deaths annually, 80%+ from coronary heart disease and stroke (Frontiers in Cardiovascular Medicine, 2022).

- [Read article](https://decodedlongevity.com/journal/vein-veldt-vascular-category)

### Vietnam's MOH — The Notification System for Wellness Products

Vietnam's Decree 46/2026 replaced the old self-declaration model with full pre-market registration for health supplements. The speed advantage versus neighbours has narrowed, but HCMC and Hanoi remain accessible if you respect the new dossier requirements.

- Category: Regulatory
- Published: 2026-03-11
- Last reviewed: 2026-03-11
- Reading time: 6 min

**Rests on:**
- Decree 46/2026/ND-CP replaced the old self-declaration model with full pre-market registration for health supplements (InCorp Vietnam, 2026).
- Decree 342/2025/NĐ-CP mandates pre-approval of all health supplement advertising effective February 2026 (InCorp Vietnam, 2026).
- Circular 50/2025/TT-BYT on clinical trials was issued 31 December 2025 and took effect 27 February 2026 (ClinRegs/NIH, 2026).
- Health supplement registration timeline post-submission runs 3-4 weeks for clean dossiers (Artixio, 2026).

- [Read article](https://decodedlongevity.com/journal/vietnam-moh-notification-system)

### Distribution Timeline — From Brand Inquiry to First Clinic Order

60-120 days from brand inquiry to first clinic order is the honest range for SEA/SSA distribution entry. The kill points are regulatory delays, payment terms misalignment, and COGS that doesn't survive 3-tier margin stacking.

- Category: Distribution
- Published: 2026-03-04
- Last reviewed: 2026-03-04
- Reading time: 6 min

**Rests on:**
- HSA Singapore cosmetic notification via PRISM is acknowledged instantly upon submission (HSA, 2026).
- Indonesia halal certification end-to-end for foreign cosmetic brands runs 3-9 months (productregistrationindonesia.com, 2026).
- Philippine FDA cosmetics CPN runs 15-30 working days; food supplement CPR 20-60 working days (TeamBench, 2026).
- Vietnam health supplement registration post-submission runs approximately 3-4 weeks for clean dossiers under Decree 46/2026 (Artixio, 2026).

- [Read article](https://decodedlongevity.com/journal/distribution-timeline-60-120-days)

### AI Agents and Clinic Workflows — What's Real in 2026

AI scribes are the only clinic-AI category that has cleared the hype line by mid-2026. Heidi Health at US$150/month, supporting 2M+ weekly consults in 110 languages across 116 countries, is the only credible multilingual option for SEA. Marketing-AI and intake-AI remain mostly overpromised.

- Category: Practitioner Tools
- Published: 2026-02-25
- Last reviewed: 2026-02-25
- Reading time: 7 min

**Rests on:**
- Heidi Health Clinician plan is US$150/month annual, supporting 2M+ consults weekly in 110 languages across 116 countries (Heidi Health Series B; Vero Scribe, 2026).
- Advanced Urology recovered over US$121,000 in clinical time and 41,100+ minutes of documentation time in 16 weeks (Heidi Health customer case study, 1 May 2025).
- Heidi Evidence launched 24 February 2026 with sources including BMJ Group, NICE, HealthPathways, EMGuidance, MIMS and Vidal (Heidi Health announcement).
- DAX Copilot (Nuance/Microsoft) prices at approximately US$600/month per provider for enterprise deployments (Commure, 2026).

- [Read article](https://decodedlongevity.com/journal/ai-agents-clinic-workflows-2026)

### The Botswana / Namibia Distribution Pattern — Underrated Markets

Botswana and Namibia are small populations with high per-capita income (Botswana US$7,696 nominal in 2024) and concentrated premium clinic networks in Gaborone and Windhoek. Regulatory paths are simpler than South Africa via ZAZIBONA priority routes — the markets reward operators who understand the scale.

- Category: Market Intel
- Published: 2026-02-18
- Last reviewed: 2026-02-18
- Reading time: 7 min

**Rests on:**
- BoMRA's medical device retention deadline for newly-scoped Class C/D devices and imaging devices is 30 June 2026 (Market Access Africa, 2026).
- NMRC operates a 6-month guaranteed evaluation under Regulation 45 fast-track pathway (NMRC, 2026).
- World Bank 2024 nominal GDP per capita: Botswana US$7,695.75, Namibia US$4,413 (World Bank).
- Botswana deposited its African Medicines Agency Treaty ratification instrument on 14 February 2025, becoming the 30th state party (Market Access Africa).

- [Read article](https://decodedlongevity.com/journal/botswana-namibia-distribution-pattern)

### Singapore HSA — the 2026 therapeutic-products updates and where the supplement-to-therapeutic line moved.

HSA's 2026 therapeutic-products guidance refines the line between supplement and therapeutic product. A view on which SKU profiles cross the line and what reclassification means.

- Category: Regulatory
- Markets: SG
- Published: 2026-04-12
- Last reviewed: 2026-04-15
- Reading time: 7 min

**Rests on:**
- HSA's 2026 therapeutic-products guidance update — published Q1 2026.
- Refined criteria for distinguishing HSP-eligible products from therapeutic products.
- Novel-actives interpretation tightened for several adjacencies operating in the supplement lane.
- Reclassification triggers GMP/PIC-S manufacturing requirements where HSP previously sufficed.
- Post-market reporting commitments differ materially between HSP and therapeutic registration.

- [Read article](https://decodedlongevity.com/journal/hsa-therapeutic-products-2026)

### GLP-1 adjacencies in the longevity line — what is in scope for distributors in Southeast Asia.

GLP-1 medications are out of scope for non-pharmaceutical distributors. The adjacencies — supplements, devices, and protocols — are not. A view on what is responsibly in scope and what is not.

- Category: Category
- Markets: SG, MY, ID, TH, VN, PH
- Published: 2026-04-13
- Last reviewed: 2026-04-15
- Reading time: 6 min

**Rests on:**
- GLP-1 receptor agonists are prescription pharmaceuticals — outside any non-pharma distribution remit.
- Adjacent supplement, device, and protocol categories are inside scope when claims-discipline holds.
- Continuous glucose monitoring is moving into the consumer-tier device space across SEA.
- Body-composition tracking devices are growing in clinic-led longevity practice.
- Claims-discipline is the gating condition — therapeutic-language is the regulatory liability.

- [Read article](https://decodedlongevity.com/journal/glp1-longevity-sea-line)

### Aesthetic-device reimbursement and out-of-pocket dynamics across SEA — the picture for 2026.

Aesthetic-device economics across the six markets are largely out-of-pocket — but the variations matter, and the 2026 movement on a small set of indications is real.

- Category: Category
- Markets: SG, MY, ID, TH, VN, PH
- Published: 2026-04-14
- Last reviewed: 2026-04-15
- Reading time: 6 min

**Rests on:**
- Aesthetic-device economics are dominantly out-of-pocket across all six markets.
- Singapore MediSave permits limited applications — narrowly drawn, not category-wide.
- Patient-financing infrastructure in Indonesia materially changed the device pricing equation in 2025–2026.
- Malaysian clinic-network consolidation shifted practitioner-side pricing power.
- Reimbursement creep visible in a small set of dermatological indications across PH and TH.

- [Read article](https://decodedlongevity.com/journal/aesthetic-device-reimbursement-sea)

### Indonesia's premium skincare market — sequencing a 2026 launch around halal, BPOM, and channel rules.

Indonesia is the largest single skincare opportunity in ASEAN and the least forgiving on dossier and channel discipline. A sequencing view for a 2026 launch.

- Category: Market sequencing
- Markets: ID
- Published: 2026-04-15
- Last reviewed: 2026-04-15
- Reading time: 7 min

**Rests on:**
- Indonesia is the largest single ASEAN market for premium skincare in unit and value terms.
- BPOM notification timeline averages 3–6 months for clean dossiers; longer for novel actives.
- BPJPH halal certification timeline runs in parallel and is the gating constraint for digital listing post-October 2026.
- Modern trade vs digital channel sequencing is the live decision — both depend on dossier status.
- Patient-financing and consumer-credit infrastructure now factor into premium-skincare pricing.

- [Read article](https://decodedlongevity.com/journal/indonesia-skincare-2026-sequencing)

### GLP-1 adjacencies in longevity practice — what sits inside and outside the prescription line.

GLP-1 prescribing remains physician-led. The adjacencies — protocol design, body-composition tracking, nutritional support, and follow-on supplementation — sit inside practitioner scope. A view on where each line falls in 2026.

- Category: longevity-science
- Markets: SG, MY, ID, TH, VN, PH
- Published: 2026-04-16
- Last reviewed: 2026-04-18
- Reading time: 7 min

**Rests on:**
- GLP-1 prescribing remains a physician-only act across all six SEA markets in 2026.
- Lean-mass loss during sustained GLP-1 use is documented; resistance-training and protein protocols are now part of standard adjunct guidance.
- Micronutrient deficiencies (notably B12, magnesium, fat-soluble vitamins) are increasingly screened pre- and intra-protocol.
- Body-composition tracking via DEXA or bioimpedance is moving from optional to default in longevity-positioned practices.
- Patient-education materials that explain the surrounding stack — not the prescription — are the durable practitioner asset.

- [Read article](https://decodedlongevity.com/journal/glp1-longevity-practitioner-line)

### How AI is reshaping the diagnostic workflow in aesthetic and functional medicine.

AI is changing intake, imaging analysis, and protocol design across aesthetic and functional practice. A view on where the assistance is real, where it overpromises, and what to evaluate before deployment.

- Category: ai-in-practice
- Markets: SG, MY, ID, TH, VN, PH
- Published: 2026-04-16
- Last reviewed: 2026-04-18
- Reading time: 8 min

**Rests on:**
- Intake summarisation and structured history extraction are the most mature workflow surfaces in 2026.
- Skin-imaging trend-tracking is in routine use; AI-driven diagnosis remains an unsettled regulatory zone.
- Protocol-recommendation engines depend on the quality and recency of the underlying knowledge base.
- Data-residency, audit-trail, and failure-mode questions decide whether a deployment is responsible.
- The most-quoted productivity gains are from documentation and intake — not from clinical decision support.

- [Read article](https://decodedlongevity.com/journal/ai-diagnostic-workflow-aesthetic-functional)

### BPC-157 and the tissue-repair evidence base — what the clinical literature actually shows.

BPC-157 has built strong preclinical interest and a growing clinical literature. A precise view on what the evidence supports, where it is thin, and how practitioners are framing it inside their protocols.

- Category: peptide-protocols
- Markets: SG, MY, ID, TH, VN, PH
- Published: 2026-04-17
- Last reviewed: 2026-04-18
- Reading time: 8 min

**Rests on:**
- Preclinical evidence base is broad: GI repair, tendon-ligament healing, vascular and neural effects in animal models.
- Clinical literature is real but smaller and heterogeneous in design quality.
- Regulatory access pathways differ materially across SEA markets in 2026.
- Most-credible practitioner positioning is as an evidence-supported adjunct in defined contexts, not as a general regenerative.
- Open questions (route of administration, dose-response, long-term safety) remain worth tracking in 2026 publications.

- [Read article](https://decodedlongevity.com/journal/bpc157-tissue-repair-evidence)

### Building a longevity practice in Singapore — regulatory, channel, and clinical considerations.

Singapore is the clearest setting in SEA to build a longevity practice and the most demanding on regulatory, premise, and claims discipline. A practical view of the build sequence in 2026.

- Category: practice-intelligence
- Markets: SG
- Published: 2026-04-17
- Last reviewed: 2026-04-18
- Reading time: 9 min

**Rests on:**
- Practitioner registration with the Singapore Medical Council is the first gating decision; specialist registration where applicable.
- MOH clinic licensing applies to dedicated premises; in-practice arrangements differ in scope.
- HSA Health Supplements Programme and therapeutic-products framework define the supplement and product stack.
- PHMC advertising rules constrain what can be claimed in marketing for medical and aesthetic services.
- Premium-positioning practices increasingly publish a transparent scope-of-practice document for patient clarity.

- [Read article](https://decodedlongevity.com/journal/building-longevity-practice-singapore)

### The seven AI and clinical-software tools every modern longevity-aesthetic practitioner should know.

From AI scribes to biomarker platforms, the seven-tool toolkit Decoded curated from forty-plus evaluated platforms. Regional viability verified for SEA and SA.

- Category: practitioner-toolkit-intelligence
- Markets: SG, MY, ID, TH, VN, PH
- Published: 2026-04-19
- Last reviewed: 2026-04-20
- Reading time: 9 min

**Rests on:**
- Forty-plus AI / clinical-software platforms evaluated; seven retained against the regional-viability bar.
- Heidi Health is the AI-scribe default for SEA; Healthbridge Clinical and MediScribe AI carry stronger SA-native posture.
- Pabau covers the integrated EMR-plus-marketing stack; Canfield (via Innomed Asia) anchors regional aesthetic imaging.
- Respond.io for SEA WhatsApp BSP; Turn.io for SA — same job, different rails.
- TruDiagnostic carries the clearest international-distributor pathway in the biomarker category; territory exclusivity for SEA / SA is on the table.
- Glass Health plus Consensus plus Elicit is the accessible CDS-and-literature stack outside the US NPI system.
- The compounding-pharmacy prescribing rail does not exist regionally today — Decoded is building it via our pathway.

- [Read article](https://decodedlongevity.com/journal/seven-ai-tools-longevity-practitioner)

### 230V/50Hz, IEC 60335-2-53, and the SAHPRA Hazardous Substances Act — the equipment-import discipline practices skip and regret.

Voltage and frequency mismatch, refrigerant choice, and SAHPRA classification are the three places clinical equipment imports go wrong. A precise view on the discipline that prevents it.

- Category: clinical-equipment-intelligence
- Markets: SG, MY, ID, TH, VN, PH
- Published: 2026-04-19
- Last reviewed: 2026-04-20
- Reading time: 8 min

**Rests on:**
- 230V/50Hz single-phase is the SEA / SA electrical standard; 110V/60Hz units do not work without a transformer that voids most warranties.
- IEC 60335-2-53 is the international safety standard for sauna heaters and is enforced at SG / MY / SA port inspection.
- SAHPRA Hazardous Substances Act gates Class I/II laser and medically classified LED imports into South Africa; SABS electrical certification is the second gate.
- Refrigerant choice (R410A versus phased-out alternatives) decides whether ice-bath chillers clear customs.
- 304 stainless is the minimum spec on heated surfaces in clinic-grade saunas; 201 corrodes within twelve months in humid SEA installations.

- [Read article](https://decodedlongevity.com/journal/voltage-50hz-sa-equipment-imports)

### Running a company on an agent stack — what we have learned operating Decoded this way.

Decoded itself runs on an agent stack across content, partner intake, regulatory monitoring, and triage. A first-person view on what works, what fails, and what the practice version of this looks like.

- Category: practice-intelligence
- Markets: SG, MY, ID, TH, VN, PH
- Published: 2026-04-19
- Last reviewed: 2026-04-20
- Reading time: 9 min

**Rests on:**
- Agent stacks fail at handoff points more often than at model output — design the handoff first.
- Prompt-versioning and configuration-as-code matter more than the headline model choice.
- Operating-manual discipline is the difference between a stack the team owns and a stack the vendor owns.
- Documentation overhead is real and persistent — bake it into the design budget, not the post-launch cleanup.
- Productised engagement (one-time, scoped, handover-complete) outperforms retainer relationships on practice-side ROI.

- [Read article](https://decodedlongevity.com/journal/running-a-company-on-agents)


## Category detail
### Premium supplements

Premium supplements are the category most often confused for a marketing exercise and most often broken by one. Decoded represents brands whose actives are evidenced, whose claims are written for the regulator before they are written for the customer, and whose dossiers are complete before a launch date is set. That posture decides whether a product survives a Singapore HSA review, a Malaysian NPR…

- [Full page](https://decodedlongevity.com/categories/supplements)

### Functional food and beverage

Functional food and beverage is the category where labelling decides survival. A product's positioning lives or dies on whether its claims pass HSA's nutrition-and-health-claims framework, BPOM's structure-and-function rules, and the category-specific guardrails the other four ASEAN regulators apply. Decoded represents brands whose proposition is intact when the regulatory permissions narrow the o…

- [Full page](https://decodedlongevity.com/categories/functional-food-and-beverage)

### Cosmeceuticals

Cosmeceuticals are the category most exposed to brand-equity erosion through channel sprawl, and the category most defensible when distribution is disciplined. Decoded represents topical brands whose formulary is coherent, whose claims are honest, and whose channel posture is preserved across the six markets — physician dispensing, clinic-led retail, premium pharmacy chains, and only the e-commerc…

- [Full page](https://decodedlongevity.com/categories/cosmeceuticals)

### Aesthetic and wellness devices

Aesthetic and wellness devices are the category in which Southeast Asia has been a residual market and is becoming a first-class one. Decoded represents Class A and Class B devices — primarily energy-based, light-based, and topical-application devices — for clinic-led distribution. The firm is selective: device launches require a regulatory dossier per market, a clinical-evidence pack a practition…

- [Full page](https://decodedlongevity.com/categories/medical-devices)

### Longevity protocols

Longevity is the category where the firm is most willing to refuse the work and most precise about which brands it engages. Decoded represents protocol-grade products — ingestibles, topicals, and devices — whose evidence pack would survive scrutiny in a clinical setting and whose channel posture matches the rest of the longevity practice (concierge clinic, longevity-focused hospital programme, qua…

- [Full page](https://decodedlongevity.com/categories/longevity)

### Wellness and recovery

Wellness and recovery is the category where clinic relevance and pharmacy permission meet. Decoded represents premium circulatory and vascular formulations — claudication, venous insufficiency, endothelial function — alongside clinic-led recovery and bath-care protocols developed with practitioners. The firm distributes in this category only where the formulation is evidenced, the labelling lane i…

- [Full page](https://decodedlongevity.com/categories/vein-and-veldt)

### Clinical equipment

Clinical equipment is the practice area where sourcing discipline decides whether a clinic owns its margin or surrenders it. Decoded represents recovery infrastructure (PEMF mats, red and infrared light arrays, ice baths, sauna heaters), clinical imaging adjacencies (skin and body-composition systems), and longevity modalities (platinum LED, photo-modulation arrays). The work is unglamorous: volta…

- [Full page](https://decodedlongevity.com/categories/clinical-equipment)


## Practitioner toolkit (gated portal — public registry surface)
### Heidi Health

- Category: AI scribe
- Status: Recommended
- SEA viable: yes
- SA viable: yes
- Last reviewed: 2026-04-20

Multi-language AI medical scribe with PDPA-aligned data residency for SEA practice.

- [Toolkit brief](https://decodedlongevity.com/practitioners/portal/toolkit/heidi-health)

### Pabau

- Category: Patient communication
- Status: Recommended
- SEA viable: yes
- SA viable: yes
- Last reviewed: 2026-04-20

Aesthetic-EMR and patient-communication suite with 500-plus aesthetic templates and built-in dictation.

- [Toolkit brief](https://decodedlongevity.com/practitioners/portal/toolkit/pabau)

### Canfield VISIA / VECTRA via Innomed Asia

- Category: Aesthetic imaging
- Status: Partnership available
- SEA viable: yes
- SA viable: no
- Last reviewed: 2026-04-20

Skin and 3D facial imaging through the long-standing regional distributor relationship.

- [Toolkit brief](https://decodedlongevity.com/practitioners/portal/toolkit/canfield-via-innomed-asia)

### Respond.io (SEA) / Turn.io (SA)

- Category: Patient communication
- Status: Recommended
- SEA viable: yes
- SA viable: yes
- Last reviewed: 2026-04-20

Two regional WhatsApp Business Solution Providers, paired by market — not by global brand.

- [Toolkit brief](https://decodedlongevity.com/practitioners/portal/toolkit/respond-io-and-turn-io)

### TruDiagnostic

- Category: Biomarker platform
- Status: Partnership available
- SEA viable: yes
- SA viable: yes
- Last reviewed: 2026-04-20

Epigenetic-age and methylation-biomarker platform with explicit international distributor and territory-exclusive pathways.

- [Toolkit brief](https://decodedlongevity.com/practitioners/portal/toolkit/trudiagnostic)

### Glass Health + Consensus + Elicit

- Category: Literature & research
- Status: Recommended
- SEA viable: yes
- SA viable: yes
- Last reviewed: 2026-04-20

The accessible clinical-decision-support and literature-synthesis stack for SEA / SA — without the US NPI gate.

- [Toolkit brief](https://decodedlongevity.com/practitioners/portal/toolkit/glass-consensus-elicit)

### Compounding Pharmacy Prescribing Rail

- Category: Prescribing infrastructure
- Status: Stocked by Decoded
- SEA viable: no
- SA viable: no
- Last reviewed: 2026-04-20

The compounding-pharmacy prescribing rail does not exist regionally. Decoded is building it.

- [Toolkit brief](https://decodedlongevity.com/practitioners/portal/toolkit/compounding-pharmacy-rail)


## Practice AI tiers (pricing inquiry-gated)
### Foundation — 4 weeks

Single-stack deployment for a clinic ready to remove its biggest operational drag.

- [Tier detail](https://decodedlongevity.com/practice-ai#foundation)

### Growth — 8 weeks

Three coordinated workflows for a clinic ready to systematise the operating layer.

- [Tier detail](https://decodedlongevity.com/practice-ai#growth)

### Transformation — 12 weeks

Full operating-layer redesign for a multi-site or post-spreadsheet practice.

- [Tier detail](https://decodedlongevity.com/practice-ai#transformation)